Yanling Chen
Impact in
- Molecular Biology top 5%
- RNA modifications and cancer
- Bacterial biofilms and quorum sensing
- RNA and protein synthesis mechanisms
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- RNA Research and Splicing
- Cancer Research top 10%
Papers in
-
- Ubiquitin and proteasome pathways 10
- Advanced biosensing and bioanalysis techniques 8
- Angiogenesis and VEGF in Cancer 8
- Protein Degradation and Inhibitors 7
- RNA modifications and cancer 6
- RNA and protein synthesis mechanisms 6
- Oncology 23
- Lymphatic System and Diseases 7
- Co-authors
- De‐Sheng Pei (3 shared papers)Wan-Ping Bian (3 shared papers)Qinkai Li (1 shared paper)Na Chen (1 shared paper)Yanbo Ma (1 shared paper)Yongfang Jia (1 shared paper)Yujie Dai (1 shared paper)Feifei She (17 shared papers)
- Journals
- PLoS ONE (4 papers)Cancer Research (3 papers)BMC Cancer (3 papers)Frontiers in Molecular Biosciences (3 papers)OncoTargets and Therapy (2 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Yanling Chen
120 papers receiving 2.6k citations
Yanling Chen's Hit Papers
Peers
Comparison fields: 5 of 149
- Molecular Biology 1.4k
- Cancer Research 270
- Molecular Medicine 89
- Health, Toxicology and Mutagenesis 234
- Oncology 365
Countries citing papers authored by Yanling Chen
This map shows the geographic impact of Yanling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanling Chen more than expected).
Fields of papers citing papers by Yanling Chen
This network shows the impact of papers produced by Yanling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanling Chen. The network helps show where Yanling Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanling Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Zebrafish as a model system to study toxicology Hit paper breakdown → | 2013 | 441 |
| 2 | 2017 | 254 | |
| 3 | 2009 | 99 | |
| 4 | 2009 | 82 | |
| 5 | 2023 | 78 | |
| 6 | Reduced expression of chemerin is associated with a poor prognosis and a lowed infiltration of both dendritic cells and natural killer cells in human hepatocellular carcinoma. | 2011 | 67 |
| 7 | 2019 | 64 | |
| 8 | 2020 | 54 | |
| 9 | 2021 | 50 | |
| 10 | 2017 | 45 | |
| 11 | 2016 | 44 | |
| 12 | 2014 | 44 | |
| 13 | 2010 | 42 | |
| 14 | 2023 | 39 | |
| 15 | 2014 | 38 | |
| 16 | 2018 | 36 | |
| 17 | 2013 | 31 | |
| 18 | 2020 | 31 | |
| 19 | 2017 | 30 | |
| 20 | 2014 | 29 |
About Yanling Chen
Yanling Chen is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Genetics, having authored 126 papers that have together received 2.6k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (10 papers), Advanced biosensing and bioanalysis techniques (8 papers), Angiogenesis and VEGF in Cancer (8 papers), Lymphatic System and Diseases (7 papers), Protein Degradation and Inhibitors (7 papers), RNA modifications and cancer (6 papers), NF-κB Signaling Pathways (6 papers) and RNA and protein synthesis mechanisms (6 papers). The work is most often cited by research in Molecular Biology (1.4k citations), Cancer Research (270 citations), Molecular Medicine (89 citations), Health, Toxicology and Mutagenesis (234 citations) and Oncology (365 citations). Yanling Chen has collaborated with scholars based in China, United States and Macao. Frequent co-authors include De‐Sheng Pei, Wan-Ping Bian, Qinkai Li, Na Chen, Yanbo Ma, Yongfang Jia, Yujie Dai, Feifei She, Xiaoqian Wang and Qiang Du. Their work appears in journals such as PLoS ONE, Cancer Research, BMC Cancer, Frontiers in Molecular Biosciences and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.